Misuse of Drugs
(Miscellaneous Amendments) (No. 2) (Jersey)
Order 2012
Made 14th September 2012
Coming into force 21st
September 2012
THE MINISTER FOR HEALTH AND SOCIAL SERVICES, in pursuance of Articles 3,
4, 5, 8, 12, 13 and 27 of the Misuse of Drugs (Jersey) Law 1978[1], and after consultation with the
Advisory Council on the Misuse of Drugs, orders as follows –
1 Schedule 2 to the Misuse of Drugs
(Jersey) Law 1978 amended
(1) In
this Article “Law” means the Misuse of Drugs (Jersey) Law 1978[2].
(2) In
Part 1 of Schedule 2 to the Law, in paragraph 1(a), after the
entry “Sufentanil” there shall be inserted the following entry –
(3) In
Part 2 of Schedule 2 to the Law –
(a) in paragraph 1(a)
after the entry “Methylphenobarbitone” there shall be inserted the
entry –
(b) for
the full stop at the end of paragraph 1(i) there shall be substituted a semi-colon;
and
(c) after
paragraph 1(i) there shall be added the following sub-paragraphs –
“(j) the following substances –
6-(2-aminopropyl)benzofuran
5-(2-aminopropyl)benzofuran;
(k) Any compound (not being
pipradrol) structurally derived from piperidine, pyrrolidine, azepane,
morpholine or pyridine by substitution at a ring carbon atom with a
diphenylmethyl group, whether or not the compound is further modified in any of
the following ways, that is to say –
(i) by substitution
in any of the phenyl rings to any extent with alkyl, alkoxy, haloalkyl or
halide groups,
(ii) by substitution
at the methyl carbon atom with an alkyl, hydroxyalkyl or hydroxy group,
(iii) by substitution at the
ring nitrogen atom with an alkyl, alkenyl, haloalkyl or hydroxyalkyl group.”.
(4) For
Part 3 of Schedule 2 to the Law there shall be substituted the
following Part –
1. The following substances,
namely –
Amineptine
Aminorex
Benzphetamine
Bromazepam
7-bromo-5-(2-chlorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one;
Brotizolam
Buprenorphine
1-4 butanediol
Camazepam
Cathine
Cathinone
Chlordiazepoxide
Chlorphentermine
Clobazam
Clonazepam
Clorazepic acid
Clotiazepam
Cloxazolam
Delorazepam
Dextropropoxyphene
Diazepam
Diethylpropion
Estazolam
Ethchlorvynol
Ethinamate
Ethyl loflazepate
Fencamfamin
Fenethylline
Fenproporex
Fludiazepam
Flunitrazepam
Flurazepam
Gamma-butyrolactone;
Halazepam
Haloxazolam
4-hydroxybutanoic acid (4-hydroxy-n-butyric
acid; gamma-hydroxybutyric acid)
Ketamine
Ketazolam
Loprazolam
Lorazepam
Lormetazepam
Mazindol
Medazepam
Mefenorex
Mephentermine
Meprobamate
Mesocarb
Methyprylone
Midazolam
Nimetazepam
Nitrazepam
Nordazepam
Oripavine
Oxazepam
Oxazolam
Pemoline
Phendimetrazine
Phentermine
Pinazepam
Prazepam
Propylhexedrine
Pyrovalerone
Temazepam
Tetrazepam
Triazolam
Zolpidem
N-Ethylamphetamine;
(b) 1-benzylpiperazine;
(c) any compound structurally derived from
1-benzylpiperazine or 1-phenylpiperazine by modification in either of the
following ways –
(i) by
substitution at the second nitrogen atom of the piperazine ring with alkyl,
benzyl, haloalkyl or phenyl substituents,
(ii) by
substitution in the aromatic ring to any extent with alkyl, alkoxy, alkylenedioxy,
halide or haloalkyl substituents.
2. The following
substances –
Androst-4-ene-3, 17-diol
5α-Androstane-3, 17-diol
4-Androstene-3, 17-dione
5-Androstene-3, 17-diol
1-Androstenediol
1-Androstenedione
5-Androstenedione
Atamestane
Bolandiol
Bolasterone
Bolazine
Boldenone
Boldione
Bolenol
Bolmantalate
1,4-butanediol
Calusterone
4-Chloromethandienone
Clostebol
Danazol
Desoxymethyltestosterone
Drostanolone
Enestebol
Epitiostanol
Ethyloestrenol
Fluoxymesterone
Formebolone
Furazabol
Gestrinone
3-Hydroxy-5α-androstan-17-one
Mebolazine
Mepitiostane
Mesbolone
Mestanolone
Mesterolone
Methandienone
Methandriol
Methenolone
Methyltestosterone
Metribolone
Mibolerone
Nandrolone
19-Nor-4-Androstene-3, 17-dione
19-Nor-5-Androstene-3, 17-diol.
19-Norandrostenedione
19-Norandrosterone
Norboletone
Norclostebol
Norethandrolone
19-Noretiocholanolone
Ovandrotone
Oxabolone
Oxandrolone
Oxymesterone
Oxymetholone
Pipradrol
Prasterone
Prostanozol
Propetandrol
Quinbolone
Roxibolone
Silandrone
Stanolone
Stanozolol
Stenbolone
Testosterone
Tetrahydrogestrinone
Thiomesterone
Trenbolone.
3. Any compound (not being
Trilostane or a compound for the time being specified in paragraph 2)
structurally derived from 17 hydroxyandrostan-3-one or from 17-hydroxy-estran-3-one
by modification in any of the following ways –
(a) by further substitution at position 17
by a methyl or ethyl group;
(b) by substitution to any extent at one or more
positions 1, 2, 4, 6, 7, 9, 11 or 16, but at no other position;
(c) by unsaturation in the carbocyclic ring
system to any extent, provided that there are no more than 2 ethylenic bonds in
any one carbocyclic ring;
(d) by fusion of ring A with a heterocyclic
system.
4. Any substance which is an ester
or ether (or, where more than one hydroxyl function is available, both an ester
and an ether) of a substance specified in paragraph 2 or described in paragraph 3.
5. Chorionic Gonadotrophin (HCG)
Non-human chorionic
gonadotrophin
Somatotropin
Somatrem
Somatropin
Zeranol
Zilpaterol.
6. Clenbuterol.
7. Any stereoisomeric form of a
substance for the time being specified in any of paragraphs 1 to 6 of
this Part not being phenylpropanolamine.
8. Any salt of a substance for the
time being specified in any of paragraphs 1 to 7 of this Part.
9. Any preparation or other product
containing a substance for the time being specified in any of paragraphs 1
to 8 of this Part.
10. The following
substances –
(a) 2-(ethylamino)-2-(3-methoxyphenyl)cyclohexanone;
(b) any stereoisomeric form
of 2-(ethylamino)-2-(3-methoxyphenyl)cyclohexanone;
(c) any ester or ether of a
substance specified in sub-paragraph (a) or (b);
(d) any salt of a substance
specified in any of sub-paragraphs (a) to (c); and
(e) any preparation or
other product containing a substance specified in any of sub-paragraphs (a)
to (d).”.
2 Schedule
to the Misuse of Drugs (Designation) (Jersey) Order 1989 amended
In Part 1 of the Schedule to the Misuse of Drugs (Designation)
(Jersey) Order 1989[3] –
(a) for
paragraph 1(a) there shall be substituted the following sub-paragraph –
1-(3,4-Methylenedioxybenzyl)butyl-(ethyl)amine
1-(3,4-Methylenedioxybenzyl)butyl-(methyl)amine
2-(1,4-Dimethoxy-2-naphthyl)-1-methylethylamine
2-(1,4-Dimethoxy-2-naphthyl)ethylamine
2-(1,4-Dimethoxy-5,6,7,8-tetrahydro-2-naphthyl)-1-methylethylamine
2-(1,4-Dimethoxy-5,6,7,8-tetrahydro-2-naphthyl)ethylamine
2-(1,4-Methano-5,8-dimethoxy-1,2,3,4-tetrahydro-6-naphthyl)-1-methylethylamine
2-(1,4-Methano-5,8-dimethoxy-1,2,3,4-tetrahydro-6-naphthyl)ethylamine
2-(2,5-Dimethoxy-4-methylphenyl)cyclopropylamine
2-(4,7-Dimethoxy-2,3-dihydro-1H-indan-5-yl)-1-methylethylamine
2-(4,7-Dimethoxy-2,3-dihydro-1H-indan-5-yl)ethylamine
2-(5-Methoxy-2,2-dimethyl-2,3-dihydrobenzo[b]furan-6-yl)-1-methylethylamine
2-(5-Methoxy-2-methyl-2,3-dihydrobenzo[b]furan-6-yl)-1-methylethylamine
2-(α-Methyl-3,4-methylenedioxyphenethylamino)ethanol
2,5-Dimethoxy-α,
4-dimethyl-phenethylamine
2-Amino-1-(2,5-dimethoxy-4-methylphenyl)ethanol
2-Amino-1-(3,4-dimethoxyphenyl)ethanol
2-Methoxyethyl(α-methyl-3,4-methylenedioxyphenethyl)amine
4-Bromo-
β,2,5-trimethoxyphenethylamine
4-Bromo-2, 5-dimethoxy-
methyl-phenethylamine
4-Iodo-2,5-dimethoxy-α-methylphenethyl(dimethyl)amine
4-Methyl-aminorex
Allyl(α-methyl-3,4-methylenedioxyphenethyl)amine
Amphetamine
Benzyl(α-methyl-3,4-methylenedioxyphenethyl)amine
Bufotenine
Cannabinol
Cannabinol derivatives except
dronabinol and except any sterioisomer of dronabinol
Cannabis
Cannabis resin
Cathinone
Coca leaf
Concentrate of poppy-straw
Cyclopropylmethyl(α-methyl-3,4-methylenedioxyphenethyl)amine
Dihydroetorphine
Dimethyl(α-methyl-3,4-methylenedioxyphenethyl)amine
Eticyclidine
Etryptamine
Gamma-butyrolactone
4-hydroxybutanoic acid
(4-hydroxy-n-butyric acid; gamma-hydroxybutyric acid)
Lysergamide
Lysergide and other N-alkyl
derivatives of lysergamide
Mescaline
Methcathinone
Methylamphetamine
N-(2,5-Dimethoxy-4-propylthiophenethyl)hydroxyl-amine
N-(4-Ethylthio-2,5-dimethoxyphenethyl)hydroxyl-amine
N-(4-sec-Butylthio-2,5-dimethoxyphenethyl)hydroxyl-amine
N.N-Diethyltryptamine
N.N-Dimethyltryptamine
N-Hydroxy-tenamphetamine
N-Methyl-N-(α-methyl-3,4-methylenedioxyphenethyl)hydro-xylamine
O-Methyl-N-(α-methyl-3,4-methylenedioxyphenethyl)hydro-xylamine
Psilocin
Raw opium
Rolicyclidine
Tenocyclidine
α,
α-Dimethyl-3,4-methylenedioxyphenethyl (methyl)amine
α,
α-Dimethyl-3,4-methylenedioxyphenethylamine
α-Methyl-3,4-methylenedioxyphenethyl(prop-2-ynyl)amine
α-Methyl-4-(methylthio)phenethylamine
(also known as 4-Methylthioamphetamine)
α-Methylphenethylhydroxylamine
(also known as N-Hydroxyamphetamine)
β
-Methoxy-3,4-methylenedioxyphenethylamine
β,2,5-Trimethoxy-4-methylphenethylamine
β,3,4,5-Tetramethoxyphenethylamine;”;
(b) in paragraph 1(n)
for the full stop there shall be substituted a semi-colon; and
(c) after
paragraph 1(n) there shall be added the following sub-paragraph –
“(o) Any
compound (not being pipradrol) structurally derived from piperidine,
pyrrolidine, azepane, morpholine or pyridine by substitution at a ring carbon
atom with a diphenylmethyl group, whether or not the compound is further
modified in any of the following ways, that is to say –
(i) by substitution
in any of the phenyl rings to any extent with alkyl, alkoxy, haloalkyl or
halide groups,
(ii) by substitution
at the methyl carbon atom with an alkyl, hydroxyalkyl or hydroxy group,
(iii) by substitution at the
ring nitrogen atom with an alkyl, alkenyl, haloalkyl or hydroxyalkyl
group.”.
3 Misuse of Drugs (General Provisions) (Jersey) Order 2009
amended
(1) In
this Article “Order” means the Misuse of Drugs (General Provisions)
(Jersey) Order 2009[4].
(2) In Article 1,
after the definition “Schedule 5 drug” there shall be inserted
the following definition –
“ ‘Schedule 6 drug’
means a controlled drug specified in Schedule 6;”.
(3) For
Article 2 there shall be substituted the following Article –
“2 Exemptions from certain provisions of Law
(1) Articles 4(1)
(importation and exportation) and 8(1) (possession) of the Law do not have
effect in respect of a Schedule 5 drug.
(2) Articles 5
(production and supply) and 8(1) of the Law do not have effect in respect of
poppy-straw.
(3) Articles 4(1), 5
and 8(1) of the Law do not have effect in respect of exempt products.
(4) Articles 4(1), 5 and 8(1) of
the Law do not have effect in respect of a Schedule 6 drug except in any
case where the importation, exportation,
production, supply, offer to supply or possession of the drug is by a person knowing
or believing that the drug will be used for the purpose of human ingestion other
than as a flavouring in
food, whether by that person or another person.”.
(4) In Schedule 1
to the Order –
(a) in paragraph 1(a)
the entry “Gammahydroxybutyrate” shall be omitted;
(b) for
the full stop at the end of paragraph 1(r) there shall be substituted a
semi-colon; and
(c) after
paragraph 1(r) there shall be added the following paragraphs –
“(s) Any compound (not being
pipradrol) structurally derived from piperidine, pyrrolidine, azepane,
morpholine or pyridine by substitution at a ring carbon atom with a
diphenylmethyl group, whether or not the compound is further modified in any of
the following ways, that is to say –
(i) by substitution
in any of the phenyl rings to any extent with alkyl, alkoxy, haloalkyl or
halide groups,
(ii) by substitution
at the methyl carbon atom with an alkyl, hydroxyalkyl or hydroxy group,
(iii) by substitution at the
ring nitrogen atom with an alkyl, alkenyl, haloalkyl or hydroxyalkyl group;
(t) 6-(2-aminopropyl)benzofuran
5-(2-aminopropyl)benzofuran.”;
(d) after
paragraph 5 there shall be added the following paragraph –
“6 The following
substances and products –
(a) 2-(ethylamino)-2-(3-methoxyphenyl)cyclohexanone;
(b) any stereoisomeric form
of 2-(ethylamino)-2-(3-methoxyphenyl)cyclohexanone;
(c) any ester or ether of a
substance specified in sub-paragraph (a) or (b);
(d) any salt of a substance
specified in any of sub-paragraphs (a) to (c); and
(e) any preparation or
other product containing a substance specified in any of sub-paragraphs (a)
to (d).”.
(5) In Schedule 2
to the Order, in paragraph 1 –
(a) after
the entry “Alphaprodine” there shall be inserted the following
entry –
(b) after
the entry “Myrophine” there shall be inserted the following
entry –
(c) after
the entry “Norpipanone” there shall be inserted the following
entry –
(d) after
the entry “Sufentanil” there shall be inserted the following
entry –
(6) for
Schedule 3 to the Order there shall be substituted the following
Schedule –
1 The
following substances, namely –
7-bromo-5-(2-chlorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one
Cathine
Chlorphentermine
Ethchlorvynol
Ethinamate
Flunitrazepam
Mazindol
Mephentermine
Meprobamate
Methylphenobarbitone
Methyprylone
Phendimetrazine
Pipradrol
Temazepam
(b) any 5,5 disubstituted
barbituric acid not being quinalbarbitone.
2 Any ester or ether of
pipradrol.
3 Any stereoisomeric form of
a substance specified in paragraph 1 or 2 not being
phenylpropanolamine.
4 Any salt of a substance
specified in any of paragraphs 1 to 3.
5 Any preparation or other
product containing a substance specified in any of paragraphs 1 to 4, not
being a preparation specified in Schedule 5.”.
(7) For
Schedule 4 to the Order there shall be substituted the following
Schedule –
1 The
following substances and products –
Alprazolam
Aminorex
Bromazepam
Brotizolam
Camazepam
Chlordiazepoxide
Clobazam
Clonazepam
Clorazepic acid
Clotiazepam
Cloxazolam
Delorazepam
Diazepam
Estazolam
Ethyl loflazepate
Fencamfamin
Fenproporex
Fludiazepam
Flurazepam
Halazepam
Haloxazolam
4-hydroxybutanoic acid
(4-hydroxy-n-butyric acid; gamma-hydroxybutyric acid)
Ketamine
Ketazolam
Loprazolam
Lorazepam
Lormetazepam
Medazepam
Mefenorex
Mesocarb
Midazolam
Nimetazepam
Nitrazepam
Nordazepam
Oxazepam
Oxazolam
Pemoline
Pinazepam
Prazepam
Propylhexedrine
Pyrovalerone
Tetrazepam
Triazolam
Zolpidem
N-Ethylamphetamine.
2 The
following substances –
5α-Androstane-3, 17-diol
4-Androstene-3, 17-dione
5-Androstene-3, 17-diol
Androst-4-ene-3, 17-diol
1-Androstenediol
1-Androstenedione
5-Androstenedione
Atamestane
Bolandiol
Bolasterone
Bolazine
Boldenone
Boldione
Bolenol
Bolmantalate
Calusterone
4-Chloromethandienone
Clostebol
Danazol
Desoxymethyltestosterone
Drostanolone
Enestebol
Epitiostanol
Ethyloestrenol
Fluoxymesterone
Formebolone
Furazabol
Gestrinone
3-Hydroxy-5α-androstan-17-one
Mebolazine
Mepitiostane
Mesbolone
Mestanolone
Mesterolone
Methandienone
Methandriol
Methenolone
Methyltestosterone
Metribolone
Mibolerone
Nandrolone
19-Nor-4-Androstene-3, 17-dione
19-Nor-5- Androstene-3, 17-diol
19-Norandrostenedione
19-Norandrosterone
19-Noretiocholanolone
Norboletone
Norclostebol
Norethandrolone
Ovandrotone
Oxabolone
Oxandrolone
Oxymesterone
Oxymetholone
Prasterone
Propetandrol
Prostanozol
Quinbolone
Roxibolone
Silandrone
Stanolone
Stanozolol
Stenbolone
Tetrahydrogestrinone
Testosterone
Thiomesterone
Trenbolone.
3 Any
compound (not being Trilostane or a compound specified in paragraph 2)
structurally derived from 17 hydroxyandrostan-3-one or from 17-hydroxy-estran-3-one
by modification –
(a) by further substitution
at position 17 by a methyl or ethyl group;
(b) by substitution to any
extent at one or more positions 1, 2, 4, 6, 7, 9, 11, or 16, but at no
other position;
(c) by unsaturation in the
carbocyclic ring system to any extent, provided that there are no more than 2 ethylenic
bonds in any one carbocyclic ring; or
(d) by fusion of ring A
with a heterocyclic system.
4 Any
substance which is an ester or ether (or, where more than one hydroxyl function
is available, both an ester and an ether) of a substance specified in paragraph 2
or paragraph 3.
5 Chorionic
Gonadotrophin (HCG)
Non-human chorionic
gonadotrophin
Somatotropin
Somatrem
Somatropin
Zeranol
Zilpaterol.
6 Clenbuterol.
7 Any stereoisomeric form of
a substance specified in any of paragraphs 1 to 6.
8 Any
salt of a substance specified in any of paragraphs 1 to 7.
9 Any preparation or other
product containing a substance or product specified in any of paragraphs 1
to 8 not being a preparation specified in Schedule 5.”.
(8) After
Schedule 5 there shall be added the following Schedule –
“SCHEDULE 6
(Article 2(4))
SCHEDULE 6 DRUGS
1 Gamma–butyrolactone
including –
(a) any salt of
gamma–butyrolactone; and
(b) any preparation or other
product containing gamma–butyrolactone or a substance specified in sub-paragraph (a).
2 1,4–butanediol
including –
(a) any substance which is
an ester or ether or both an ester and
ether of 1,4‑butanediol;
(b) any salt of
1,4–butanediol or of a substance specified in sub-paragraph (a); and
(c) any preparation or
other product containing 1,4–butanediol or a substance specified in sub-paragraph (a)
or (b).”.
4 Citation and commencement
This Order shall be cited as the Misuse of Drugs (Miscellaneous Amendments)
(No. 2) (Jersey) Order 2012 and shall come into force 7 days
after it is made.
deputy a.e. pryke of trinity
Minister for Health and Social Services